Sanomedics Inc

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Sanomedics Inc and buy or sell other stocks, ETFs, and their options commission-free!

About SIMH

Sanomedics International Holdings, Inc. is a medical technology holding company that focuses on game changing products, services and ideas – a place where physicians, entrepreneurs, and medical companies can work together to drive innovative technologies through concept, development, and ultimately commercialization. They plan to grow their existing business organically and through strategic acquisitions specifically relating to sleep disorder diagnosis treatments. 

CEO
David C. Langle, CPA
CEODavid C. Langle, CPA
Employees
Employees
Headquarters
Miami, Florida
HeadquartersMiami, Florida
Founded
2009
Founded2009
Employees
Employees

SIMH Key Statistics

Market cap
Market cap
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
150.00K
Average volume150.00K
High today
High today
Low today
Low today
Open price
Open price
Volume
0.00
Volume0.00
52 Week high
$0.0002
52 Week high$0.0002
52 Week low
$0.0001
52 Week low$0.0001

Stock Snapshot

Sanomedics Inc(SIMH) stock is priced at $0.00.

On 2026-08-09, Sanomedics Inc(SIMH) stock opened at —, reached a high of —, and a low of —.

The Sanomedics Inc(SIMH)'s current trading volume is 0, compared to an average daily volume of 150K.

During the past year, Sanomedics Inc(SIMH) stock moved between $0.00 at its lowest and $0.00 at its peak.

During the past year, Sanomedics Inc(SIMH) stock moved between $0.00 at its lowest and $0.00 at its peak.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.